Breaking News

Who is shaping Kamala Harris's health care policy?

October 10, 2024
Ruby Wallau for STAT

STAT+ | 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease

Additional cancer cases create difficult choices for families facing a devastating neurological disorder with few alternative treatments.  

By Jason Mast


STAT+ | 10 people to watch who could shape health policy in a Harris administration

Harris has advocated for reproductive health access and addressing maternal mortality disparities. 

By Rachel Cohrs Zhang


Africa CDC faults U.S. government over Marburg-related travel advisory to Rwanda

The African CDC and Rwandan government objected to the Level 3 travel advisory issued by the U.S., saying Rwanda was being punished for its transparency.

By Helen Branswell



Bill Nye.
Rob Kim/Getty Images for Global Citizen

Bill Nye, Science Guy, speaks out on ataxia

Ataxia, often misdiagnosed as Parkinson's or multiple sclerosis, has affected Nye's family — and now he's spreading the word on genetic testing.

By Anil Oza


STAT+ | Sarepta's gene therapy is fully approved, but its stock has tanked. Here's why

The company is trading at 3.5 times next year's sales — historically cheap by comparable biotech standards. 

By Adam Feuerstein


STAT+ | Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

National Science Foundation data: 62% of biomedical scientists who had a job lined up were bound for industry in 2023, down from 67% in 2022

By Jonathan Wosen


Sen. Elizabeth Warren expressed concern about the deal between Novo Holdings and Catalent.
Alex Wong/Getty Images

STAT+ | Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants

Critics say the would give Novo Nordisk an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

By Ed Silverman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments